TBP AUDIO FILES

Laboratory Pitfalls and Repeat Testing as a Feature

William

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 23:21
SPEAKER_01

Welcome to the deep dive. Today we are looking at a fascinating, and well, frankly, a pretty unsettling paradox in modern medicine.

SPEAKER_00

Aaron Ross Powell Oh, absolutely. It's something that really challenges how we think about testing.

SPEAKER_01

Aaron Ross Powell Right. It's about how precise laboratory numbers can actually create this diagnostic illusion.

SPEAKER_00

Aaron Ross Powell Yeah, which is a wild concept when you're used to trusting the math.

SPEAKER_01

Exactly. So our mission today is to really explore how forcing dynamic human biology into these rigid mathematical boxes can lead both doctors and you know patients completely astray.

SPEAKER_00

And we have some really phenomenal source material to help us do that.

SPEAKER_01

We do. We are pulling all of this from Dr. William Ayrd's expert text on precision and reliability in von Wilbrand disease testing, or VWD for short.

SPEAKER_00

A truly definitive text on the subject.

SPEAKER_01

It really is. Now I want you to imagine, just for a second, that you are sitting in a doctor's office. You're holding a medical lab report in your hands.

SPEAKER_00

We've all been there.

SPEAKER_01

Right. You look down at the paper and it looks incredibly official. It's printed on that crisp paper. There are barcodes in the corner, and right there in the middle is a number summarizing your blood test results.

SPEAKER_00

And that number feels exact.

SPEAKER_01

Yes. It feels definitive. I mean it's math, right? But what if I told you that the number you are looking at might not be a permanent truth about your body.

SPEAKER_00

Which is a scary thought for a lot of people.

SPEAKER_01

Truly. What if instead of a high definition photograph of your biology, that highly specific scientifically generated number is actually just a, well, a blurry snapshot of a moving target?

SPEAKER_00

That is the core of the issue right there.

SPEAKER_01

Okay, let's unpack this. We aren't just doing a medical lesson today. We are really using this specific blood disorder as a masterclass in critical thinking.

SPEAKER_00

Because it forces you to look at the danger of treating a single data point as absolute truth.

SPEAKER_01

Exactly.

SPEAKER_00

And the clinical reality of diagnosing von Willebrand disease, which is, you know, the most common inherited bleeding disorder in humans, it demonstrates exactly why that critical thinking is so necessary.

SPEAKER_01

Because we just trust the lab values unconditionally.

SPEAKER_00

Right. We are conditioned to trust that precision. We view them as binary. You know, you are sick or you were healthy, you have a disease, or you don't.

SPEAKER_01

But it's not that simple, is it?

SPEAKER_00

Not at all. The label on a patient's chart in this specific field can actually change from one day to the next, even if their underlying biological state hasn't meaningfully changed at all.

SPEAKER_01

Wow. Okay, so before we can even begin to understand why the lab tests are so tricky, we have to understand the biological tightrope our blood is walking every single day.

SPEAKER_00

It really is a tightrope.

SPEAKER_01

The text refers to hemostasis, which is you know the body's process of stopping bleeding as a regulated compromise. So it's not just this one-directional defense shield where more clotting is always better.

SPEAKER_00

No, and viewing clotting as just a simple patch for a leak really ignores the sheer physical force of the human vascular system.

SPEAKER_01

Aaron Powell Right, because there's a lot of pressure in there.

SPEAKER_00

Exactly. It is a highly pressurized, super dynamic environment. If your blood is too eager to clot, you develop dangerous blockages.

SPEAKER_01

Like thrombosis.

SPEAKER_00

Yes, thrombosis, which can obviously lead to strokes or heart attacks. But on the flip side, if the blood is too reluctant to clot, you risk uncontrolled bleeding from minor injuries.

SPEAKER_01

So it's a constant negotiation.

SPEAKER_00

Second by second. The body has to maintain fluidity while being ready to solidify instantly when damage actually occurs.

SPEAKER_01

And the star negotiator in this process is von Willebrand Factor or VWF.

SPEAKER_00

Yep, the main player.

SPEAKER_01

So this is a protein circulating in your blood, and its job is essentially to capture platelets to stop you from bleeding. But the source material emphasizes that this protein is massive, like it's huge, and it's incredibly sticky.

SPEAKER_00

It is. To visualize just how massive it is, we have to talk about how it's structured.

SPEAKER_01

Okay.

SPEAKER_00

So VWS is secreted as a multimer. Think of a multimer like a long chain of coiled, sticky pearls.

SPEAKER_01

Okay, sticky pearls, got it.

SPEAKER_00

And in high shear vascular beds, those are the really narrow blood vessels where the blood is rushing incredibly fast under high pressure. The sheer mechanical force of the blood physically uncoils those long chains.

SPEAKER_01

Oh wow. It physically pulls them apart.

SPEAKER_00

Exactly. When a protein unfurls, it exposes these active binding sites that grab onto passing platelets. It is brilliantly effective.

SPEAKER_01

But I'm guessing that massive size and stickiness make it highly dangerous if it's left unchecked.

SPEAKER_00

Incredibly dangerous. You just have sticky nuts catching everything.

SPEAKER_01

Right. So enter the regulator. A protein with a very catchy name, uh 8MTS13.

SPEAKER_00

Rolls right off the tongue.

SPEAKER_01

Totally. The text describes it acting like a pair of molecular scissors. Its entire job is to float around and trim down the Von Wilbrand factor.

SPEAKER_00

Because you need to manage those sticky nets.

SPEAKER_01

Exactly. It snips those massive, sticky multi-cerumers into smaller, safer pieces just to keep everything in check.

SPEAKER_00

Right. The scissors keep the whole system calibrated. ADMTS-13 doesn't switch the VWF off completely.

SPEAKER_01

It just trims it down.

SPEAKER_00

Yes. So the body retains just enough adhesive potential to stop a bleed without leaving massive nets floating around that could cause a blockage.

SPEAKER_01

Okay, that makes sense.

SPEAKER_00

And von Willebrand disease, the bleeding disorder, and a condition called TTP, which stands for thrombotic thrombocytopenic purpura, a severe clotting disorder, they are opposite failures of this exact same regulatory axis.

SPEAKER_01

Aaron Powell I want to make sure I'm fully visualizing this. Let me try an analogy.

SPEAKER_00

Go for it.

SPEAKER_01

It sounds like von Willebrand factor is essentially the gas pedal for blood clotting, and 8 MTS13 is the brakes.

SPEAKER_00

Okay, yeah.

SPEAKER_01

So if you don't have enough gas or the gas pedal is broken, you bleed. That's VWD.

SPEAKER_00

Correct.

SPEAKER_01

But if the brakes fail, if those molecular scissors just stop snipping, the car speeds out of control, the blood gets way too sticky, and you get dangerous spontaneous clots. That's TTP.

SPEAKER_00

I love that. The mechanical comparison highlights exactly what doctors are trying to manage here. The goal of treating these conditions isn't to slam on the gas or just rip out the brakes entirely.

SPEAKER_01

Right. You want to drive safely.

SPEAKER_00

Exactly. The medical objective is achieving what the text calls proportionate hemostasis.

SPEAKER_01

Proportionate hemostasis.

SPEAKER_00

A clinician wants to provide enough structural support to reduce a patient's bleeding risk while completely avoiding the creation of an unnecessary thrombotic risk. It is a very delicate balancing act.

SPEAKER_01

Aaron Powell Which brings us directly to the lab reports. Since this biological system relies on such a delicate balance, you would naturally assume that our modern laboratory tests measure it perfectly.

SPEAKER_00

You would hope so.

SPEAKER_01

Right. But here's where the biology radically clashes with the math. The lab report spits out these exact numbers. You get a result that says your VWF activity is 34 IUDL or 47 IUDL.

SPEAKER_00

And that looks very authoritative.

SPEAKER_01

It really does. But hold on, before we talk about a result of 34 or 47, we need to ground this. The report says IUDL. For someone holding this paper, what is that actually measuring?

SPEAKER_00

That's a great question.

SPEAKER_01

Aaron Powell Are they physically like counting the individual proteins floating in the blood?

SPEAKER_00

No, they're definitely not counting individual molecules. IUDL stands for international units per deciliter. Because VWF is so complex, labs don't just count the pieces. Instead, they take a standardized pool of blood plasma from about 100 healthy donors and they assign that pool an arbitrary value of 100 IUDL.

SPEAKER_01

So it's like a baseline.

SPEAKER_00

Exactly. It represents a 100% normal baseline. When a patient's blood is tested, the lab is comparing the patient's sample against that standardized pool.

SPEAKER_01

Oh, I see.

SPEAKER_00

So a result of 47 IUDL simply means the sample showed 47% of the activity or concentration found in the reference standard.

SPEAKER_01

Okay, that makes so much more sense. It's a ratio, it's not a head count.

SPEAKER_00

Exactly.

SPEAKER_01

And the text notes that the meaning of that ratio depends entirely on where it falls on the spectrum. If a patient comes in with a value of eight IUDL, the source material says that is a clear, profoundly abnormal signal.

SPEAKER_00

There is zero ambiguity there.

SPEAKER_01

Right. There is a massive deficiency of the gas petal protein. The certainty is high. But as you move closer to the threshold of what is considered normal, things get very blurry.

SPEAKER_00

Very blurry.

SPEAKER_01

The text highlights the 30 to 50 IUDL range as the gray zone. It actually says this is where certainty dissolves.

SPEAKER_00

Which is a perfect way to phrase it.

SPEAKER_01

Wait, I'm confused though. If a patient's test jumps from an abnormal 48 on Tuesday to a normal 53 on Thursday, doesn't that just mean they got better? Like, how can a bleeding disorder just vanish in 48 hours?

SPEAKER_00

Well, the bleeding disorder didn't vanish. What vanished was the illusion of the test's stability.

SPEAKER_01

What's fascinating here is go ahead and explain that.

SPEAKER_00

Yeah, what's fascinating here is that human biology exists on a continuous spectrum, but medical systems, insurance cards, and diagnostic criteria, they require strict categorical boxes.

SPEAKER_01

They need a yes or no.

SPEAKER_00

Right. In that 30 to 50 IUDL range, the patient is hovering right on the edge of the diagnostic box. A five-point fluctuation from 48 to 53 represents a tiny expected flutter in the biological data, or even just the laboratory instrument.

SPEAKER_01

Just normal noise.

SPEAKER_00

Exactly. The patient's physical bleeding risk hasn't changed at all in those 48 hours, but because they crossed an arbitrary threshold of 50, the medical label flips from disease to normal.

SPEAKER_01

That is wild. The label moves, but the patient doesn't.

SPEAKER_00

Precisely.

SPEAKER_01

And the plot thickens even more because that flutter in the data might not even be coming from the patient's biology.

SPEAKER_00

Right. There are outside factors.

SPEAKER_01

The text dives into how easily outside factors can manipulate that final number before the lab even runs the test. Let's talk about the ice.

SPEAKER_00

Oh, the ice trap.

SPEAKER_01

Yeah. The text notes that transporting blood for VWF testing on ice instead of at ambient room temperature can artificially lower the von Willebrand factor. Why does ice ruin the test?

SPEAKER_00

Extreme cold triggers a physical reaction in the blood sample. Because VWF is such a massive, complex protein, dropping the temperature causes those large maltiners to precipitate.

SPEAKER_01

So they just fall apart.

SPEAKER_00

They literally clumped together and fall out of the liquid plasma solution, sinking right to the bottom of the tube. Oh wow. So when the laboratory technician pipettes the liquid plasma off the top to run the test, the VWF appears to be missing. The cold temperature artificially creates a severe deficiency in the test tube that does not actually exist in the patient's body.

SPEAKER_01

So a well-meaning nurse trying to preserve a sample on ice could accidentally manufacture a lab result that looks like a bleeding disorder.

SPEAKER_00

Happens more often than you'd think.

SPEAKER_01

That is terrifying. Add in transport delays, clotting in the tube, or freestyle issues, and you are adding massive amounts of noise exactly when you need a clear signal.

SPEAKER_00

The preanalytic errors are a massive headache.

SPEAKER_01

But the sabotage isn't just external. The patient's own body can temporarily manipulate the numbers too. The text calls this a massive interpretive trap because von Willebrand factor is an acute phase reactant.

SPEAKER_00

Meaning it reacts to stress.

SPEAKER_01

Meaning it reacts to stress. Okay, explain that.

SPEAKER_00

Well, the endothelial cells lining the blood vessels, they store reserve pools of VWF. When the body perceives stress, whether that is systemic inflammation, a viral infection, physical trauma, vigorous exercise, or even pregnancy, it prepares for the possibility of bleeding by dumping those reserves into the bloodstream.

SPEAKER_01

Oh, so the levels just spike dramatically. Here's where it gets really interesting. Testing someone's von Wilbrand factor during a stressful event or a severe infection is basically like measuring their resting heart rate while they're running away from a bear.

SPEAKER_00

That is a brilliant way to put it.

SPEAKER_01

It's completely masking their actual baseline.

SPEAKER_00

Completely.

SPEAKER_01

Imagine a patient who truly has a baseline low VWF. Like they have a real bleeding risk, but they get their blood drawn right after giving birth or after an intensely panicked drive to the hospital.

SPEAKER_00

They are stressed to the max.

SPEAKER_01

Right. The doctor looks at the lab report, sees a normal number because of the stress spike, and says, Well, great news, you don't have a bleeding disorder.

SPEAKER_00

And falling into that trap provides profound false reassurance. Framing the diagnostic inquiry simply as, is the number normal, is a fundamental failure of clinical judgment.

SPEAKER_01

So what should they be asking?

SPEAKER_00

The rigorous discipline question must always be: was the patient's biology at baseline when this specific sample was drawn?

SPEAKER_01

Right, because of the stress factor.

SPEAKER_00

Yes. For a disease built on an acute phase reactant, the concept of normal cannot be separated from the biological context of the moment.

SPEAKER_01

Context is everything.

SPEAKER_00

Right.

SPEAKER_01

But what happens when we zoom out? We've established that the specific moment of the blood draw is highly sensitive to like a recent infection or an ice pack.

SPEAKER_00

Right.

SPEAKER_01

But what happens when we look at the passage of time over years or decades? The source text points out that the testing technology itself is a moving target.

SPEAKER_00

This is such a confusing area for patients. Patients often compare a laboratory result from 2008 to a result from 2026, assuming the yardstick hasn't changed. But it has. Significantly. Older methodologies, specifically the ristacetin cofactor assays, relied on adding a dead antibiotic called ristacetin into the test tube to artificially force the patient's VWF to bind to platelets.

SPEAKER_01

Which sounds a bit messy.

SPEAKER_00

It is a clunky test. It is notoriously prone to false low readings, especially if a patient has harmless genetic variations that block the antibiotic but don't actually impair their blood clotting in real life. Newer methodologies like platelet binding assays, they use recombinant technology to measure the binding capacity directly without relying on that artificial antibiotic trigger.

SPEAKER_01

So if a patient's number jumps up over a decade, they might think, oh, my health is improving, but it's actually just the laboratory upgrading its technology.

SPEAKER_00

Exactly. The test just got better.

SPEAKER_01

That makes tracking this condition over a lifetime incredibly complicated. But even if the lab technology stays exactly the same, the body doesn't.

SPEAKER_00

No, it doesn't.

SPEAKER_01

The text brings up the normalization problem. As we age, our von Wilbrand factor naturally increases. Why does it go up just because we get older?

SPEAKER_00

Aging involves cumulative wear and tear on the cardiovascular system. Over decades, the endothelial cells lining the blood vessels experience low-grade chronic inflammation and stiffening.

SPEAKER_01

Which stresses them out.

SPEAKER_00

Right. As a response to that chronic endothelial irritation, the cells steadily release more von Willebrand factor into the bloodstream.

SPEAKER_01

Ah, the stress dump again.

SPEAKER_00

Exactly. So a child diagnosed with type 1 von Willebrand disease, who truly struggles with severe nosebleeds or surgical bleeding, they might see their lab number slowly drift up into the normal range by the time they are 50.

SPEAKER_01

So if a patient normalizes with age, how does a doctor responsibly update their chart? Don't we risk completely ignoring their entire history of bleeding just because today's number, you know, fueled by aging and inflammation, crossed a magical threshold?

SPEAKER_00

It's a huge risk.

SPEAKER_01

You can't just take a giant eraser to their medical history.

SPEAKER_00

No, erasing the diagnosis reflexively leaves the patient incredibly vulnerable, especially if they are about to undergo a major surgery.

SPEAKER_01

Right, because they still have the underlying issue.

SPEAKER_00

Exactly. The source material emphasizes that a diagnosis of von Willebrand disease must be earned through rigorous pattern recognition over time.

SPEAKER_01

Pattern recognition.

SPEAKER_00

Yes. A responsible doctor recalibrates the patient's risk narrative. They evaluate the original bleeding history, the family history, and how the patient responded to prior therapies, recognizing that the elevated number in adulthood might just be an age-related mask over a fundamentally defective hemostatic system.

SPEAKER_01

It's treating the patient like a human being with a history, not just a data point on a Tuesday.

SPEAKER_00

Exactly.

SPEAKER_01

And doctors can't take the easy way out either. The text warns against false escape hatches.

SPEAKER_00

Yes, the basic screening tests.

SPEAKER_01

Right. You can't just run a standard basic blood test like an APTT. Those are common clotting tests. But the text says a normal APTT absolutely does not exclude VWD. Why do those basic tests fail here?

SPEAKER_00

Basic tests like the APTT evaluate the secondary clotting cascade. Those are the chemical reactions that form a hard fibrin clot much later in the process.

SPEAKER_01

Okay, so it's looking at the wrong part of the process.

SPEAKER_00

Exactly. They are entirely blind to the initial platelet plug phase of hemostasis, which is precisely where von Willebrand factor operates. Oh wow. Relying on an APTT as an escape hatch to avoid deeper investigation is frankly clinical negligence.

SPEAKER_01

So what do they need to run instead?

SPEAKER_00

Diagnosing or excluding this disorder requires a specific mandatory core panel that includes VWF antigen, VWF activity, and factor eight.

SPEAKER_01

Wait, let's break that core panel down. Antigen, activity, and factor eight. What is the fundamental difference between testing the antigen and testing the activity?

SPEAKER_00

The antigen test is simply taking roll call. It asks the quantitative question. How much of the von Willebrand protein is physically present in the blood?

SPEAKER_01

Okay, just the amount.

SPEAKER_00

Right. The activity test asks the functional question. Of the protein that is present, does it actually work to catch platelets?

SPEAKER_01

So quantity versus quality.

SPEAKER_00

Exactly. You need both to determine if a patient has a quantitative shortage or a functional defect.

SPEAKER_01

And what about factor eight?

SPEAKER_00

Factor eighth is included because Von Wilbrand factor acts as a carrier and protector for factor eight in the bloodstream.

SPEAKER_01

Oh, so they travel together.

SPEAKER_00

Yes. If VWF is drastically low, factor eight is left unprotected and degrades rapidly.

SPEAKER_01

Aaron Powell That makes perfect sense. It's like a package deal.

SPEAKER_00

It is.

SPEAKER_01

Which brings us to the ultimate solution the text offers, which is the discipline diagnosis.

SPEAKER_00

My favorite part.

SPEAKER_01

Right. With all these variables, the ice packs in transport, the patient having a cold, the aging process, the changing lab tech, how could any doctor confidently make a diagnosis? The answer lies in how we use repeat testing.

SPEAKER_00

And repeat testing is frequently misunderstood by patients as a sign of a doctor's indecision or confusion.

SPEAKER_01

Yeah, you think, why didn't you get it right the first time?

SPEAKER_00

Exactly. But in the context of a highly volatile biological system and tests prone to pre-analytic sabotage, repeat testing is the ultimate form of quality control. It is a necessary respect for the complexity of human biology.

SPEAKER_01

Let's ground this in a real-world application. The source text gives us a fantastic reflect and apply case.

SPEAKER_00

This case is so illustrative.

SPEAKER_01

Yeah, so we have a 28-year-old woman. She has a history of heavy menstrual bleeding, and she's referred to the doctor after suffering a postpartum hemorrhage, so heavy bleeding after childbirth. Her sister also has a history of heavy bleeding.

SPEAKER_00

Important context.

SPEAKER_01

Very. The doctor runs the core panel two weeks after the patient had a respiratory infection, and the VWF activity comes back at 44 IUDL.

SPEAKER_00

Which places her squarely in the ambiguous 30 to 50 gray zone.

SPEAKER_01

Right in the middle of it.

SPEAKER_00

And more importantly, the sample was drawn in the wake of a respiratory infection, which is a biological stressor that artificially drives VWF levels up.

SPEAKER_01

So her actual baseline is lower.

SPEAKER_00

Her baseline is likely much lower than 44.

SPEAKER_01

Right. So three months later, when she is feeling completely, well, no infection, totally at her biological baseline, they repeat the test. This time the VWF activity comes back at 53 IUDL.

SPEAKER_00

Which crosses the magic threshold.

SPEAKER_01

Exactly. So what does this all mean? If a doctor just looks at that 53, sees it as over the 50 threshold, and discharges her, they are totally ignoring her family history.

SPEAKER_00

Completely ignoring it.

SPEAKER_01

They are ignoring the terrifying postpartum hemorrhage she actually experienced. They are treating a 53 as if it guarantees safety when we just spent the last 10 minutes proving how noisy and fragile these numbers are.

SPEAKER_00

Discharging her based solely on that 53 demonstrates the absolute danger of binary thinking. And this exact tension is the subject of fierce debate within major medical guidelines.

SPEAKER_01

Oh, really? There's a debate.

SPEAKER_00

Oh, yes. The source text impartially lays out two competing philosophies. The 2021 guidelines from ASH and ISTH lean heavily toward making the diagnosis for anyone with abnormal bleeding and VWF levels anywhere below 50.

SPEAKER_01

Even if it's right on the edge.

SPEAKER_00

Yes. Their primary objective is safeguarding access to care. Without the official medical label, a patient's insurance may refuse to cover the expensive medications needed to prevent a severe hemorrhage during a future surgery.

SPEAKER_01

Wow. Access is a huge deal. The label is basically the key to the pharmacy.

SPEAKER_00

It is.

SPEAKER_01

But the text presents the other side too.

SPEAKER_00

Yes. The 2024 guidelines from the BSH and UKH CDO take a much more conservative stance. They emphasize extreme caution in the 30 to 50 range, noting that the statistical link between the disease and actual bleeding symptoms becomes incredibly weak in that gray zone.

SPEAKER_01

So they want to avoid overdiagnosing.

SPEAKER_00

Precisely. Their objective is protecting patients from over-medicalization. They want to avoid hanging a lifelong, potentially stigmatizing disease label on a patient simply because a noisy lab test fluttered to 48 on a Tuesday.

SPEAKER_01

And the text makes it clear: neither guideline is wrong. Both are perfectly valid frameworks, prioritizing different ethical outcomes in medicine.

SPEAKER_00

Yes, access versus avoiding harm.

SPEAKER_01

But they prove that guidelines provide structure, not absolute certainty. The doctors still have to do the hard work of synthesizing all that messy data.

SPEAKER_00

If we connect this to the bigger picture, the success of a discipline diagnosis ultimately depends on how a thoughtful clinician frames this biological uncertainty for the patient.

SPEAKER_01

How they communicate it.

SPEAKER_00

Right. A doctor who says your test is unreliable, so we have to repeat it, well, that destroys the patient's trust in the medical system.

SPEAKER_01

Oh, totally. You'd think the lab was just broken.

SPEAKER_00

But a skilled clinician says your biology naturally fluctuates based on stress, temperature, and time. We are going to test this again to find your true biological baseline.

SPEAKER_01

That is so much better.

SPEAKER_00

That approach preserves trust and actually invites the patient to understand their own body.

SPEAKER_01

I really love that phrasing.

SPEAKER_00

Yeah.

SPEAKER_01

We are trying to find your true baseline. It acknowledges that you are a living, breathing, changing ecosystem, not just some static machine churning out fixed data points.

SPEAKER_00

A dynamic ecosystem, exactly.

SPEAKER_01

And that really brings us to the core takeaway of this entire deep dive. A diagnosis in this gray zone is a narrative, not a threshold. It requires the doctor and the patient to sit down and integrate the bleeding history, the family history, the assay methods, the temperature of the blood tube, and the patient's current state of life.

SPEAKER_00

It is the ultimate integration problem. Laboratory numbers organize our clinical decision making, but they simply cannot replace human judgment.

SPEAKER_01

So as we wrap up, I want to bring us back to that image from the very beginning. You're sitting in the office looking at that lab report. It looks so precise.

SPEAKER_00

With all its barcodes and exact decimals.

SPEAKER_01

But now you know it is just a snapshot, heavily influenced by the context of the moment it was taken. Which leaves me with a final slightly provocative thought for you to mull over as you go about your day.

SPEAKER_00

Oh, I'm ready.

SPEAKER_01

If our blood, you know, the very fluid keeping us alive, is this much of a shifting context-dependent ecosystem? Well, how many other absolute medical labels sitting in our files right now are actually just noisy snapshots of a single unrepresentative moment in time?

SPEAKER_00

That is a phenomenal question to walk away with.

SPEAKER_01

Truly. Thank you so much for joining us on this deep dive into the fascinating, frustrating, and incredibly dynamic world of our own biology. Keep questioning the numbers, and we will see you next time.